NCT03392207View on ClinicalTrials.gov

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

CompletedOBSERVATIONAL
Enrollment

403

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

July 17, 2018

Study Completion Date

September 14, 2018

Conditions
Influenza, HumanOrthomyxoviridae InfectionsRNA Virus InfectionsRespiratory Tract InfectionsVirus DiseasesVaccinesPhysiological Effects of Drugs
Interventions
BIOLOGICAL

Seasonal Influenza Vaccine

Trivalent, Fragmented, Inactivated Seasonal Influenza Vaccine (2018 Southern Hemisphere Season) produced at Butantan Institute

Trial Locations (2)

Unknown

Crie - Unifesp, São Paulo

05503-900

Avenida Vital Brasil 1500, São Paulo

Sponsors

Lead Sponsor

Butantan Institute
All Listed Sponsors
lead

Butantan Institute

OTHER_GOV